In a late-night reversal, Pfizer's former CEO and CFO issued a statement saying they now support the company's existing ...

With a new presidential administration next year, FDA Principal Deputy Commissioner Namandjé Bumpus would be in line to lead ...

GSK said Wednesday that it is paying up to $2.2 billion to resolve 93% of its US state-based liability cases related to its ...

Artificial intelligence has its Nobel Prize moment. On Tuesday, the Nobel Prize in Physics went to a pair of longtime AI ...

The three major PBMs being sued by the FTC have filed motions to disqualify the Democratic commissioners who would rule on ...

While Medicare doesn't currently cover anti-obesity drugs, a new report from the Congressional Budget Office estimates that ...

If all goes according to plan, insitro could finally start testing its first drug in clinical trials in 2026, eight years ...

This year's prestigious Nobel Prize in Chemistry has been awarded to David Baker, the director of the Institute for Protein ...

Clearside Biomedical reported positive results from a Phase 2b trial of its tyrosine kinase inhibitor in patients with wet ...

London-based startup Basecamp Research has closed a $60 million Series B round that will help expand its genomic database and ...

Concentra Biosciences, a shell company from Tang Capital, wants to buy another biotech that has found itself in a bind. Kevin ...

Thera, Richter, InnoCare and Scholar Rock: Crinetics prices $500M offering: The San Diego biotech upsized the offering by $100 million from $400 million. The biotech last month asked the FDA to ...